A review of recent trends and remaining challenges in bispecific antibody (bsAb) production has been published.
Q4 2024 Earnings Call Transcript February 6, 2025 Neurocrine Biosciences, Inc. misses on earnings expectations. Reported EPS ...
Zacks.com on MSN17h
DNLI Reports Upbeat Longer-Term Data From Hunter Syndrome StudyDenali Therapeutics DNLI reported primary analysis data from an early to mid-stage study of its pipeline candidate, tividenofusp alfa (DNL310), in 47 patients with Hunter syndrome (MPS II) over a ...
2-Year U.S. Treasury Note Continuous Contract $102.723-0.141-0.14% 5-Year U.S. Treasury Note Continuous Contract $106.461-0.273-0.26% 10-Year U.S. Treasury Note Continuous Contract $109.219-0.359 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback